Perhaps the question most often posed by entrepreneurs and start-up company executives is, "What are device investors looking for these days?" At Windhover’s IN3 West conference, held in Las Vegas, NV, in February of this year, we attempted to provide several different perspectives on that question through panel presentations. In this article, we are excerpting portions of a discussion that featured two prominent organizations with long-term commitments to medical device investing, but which operate from different points on the investor spectrum: Medtronic PLC and the Carlyle Group.
Beginning in the late 1990s, Medtronic went through one of the most transformative dealmaking cycles in industry history with its...
